It’s been hard not to notice how slow this year has been when it comes to bringing new companies to the market via initial public offerings (IPOs). Last quarter’s market selloff plus government shutdown-related staffing issues at regulatory agencies such as the Securities and… Read More
Genia Turanova, Chief Investment Strategist for Game-Changing Stocks and Fast-Track Millionaire, is a financial writer and money manager whose experience includes serving for more than a decade as a portfolio manager and Investment Committee member for a New York-based money management firm. Genia also researched, wrote and managed recommendations for several investment advisories. From 2011 to 2016, she served as Editor of the award-winning Leeb Income Performance newsletter. Genia also wrote for The Complete Investor, another award winner, from 2003 to 2016. During that time, Genia was responsible for several portfolios, including the "Income/Value" portfolio and the "FastTrack" portfolio. Genia's academic credentials include an MBA in Finance and Investments from the Zicklin School of Business, Baruch College in New York City. Genia is a CFA Charterholder.
Analyst Articles
Are These The Next Biotech Buyout Targets?
For biotech investors, the year has started with a bang. First, it was Bristol-Myers Squibb’s (NYSE: BMY) enormous $74 billion bid for Celgene (Nasdaq: CELG), one of the largest biotech companies in the world. Right on its heels came a smaller but still significant move — the announcement on Jan. 7 of Eli Lilly’s (NYSE: LLY) intended $8 billion acquisition of Loxo Oncology (Nasdaq: LOXO). —Recommended Link— Market Rally Forecast For The Next 3 Days Did you know the stock market rallied during every government shutdown over the past 25 years? In fact, this time,… Read More
For biotech investors, the year has started with a bang. First, it was Bristol-Myers Squibb’s (NYSE: BMY) enormous $74 billion bid for Celgene (Nasdaq: CELG), one of the largest biotech companies in the world. Right on its heels came a smaller but still significant move — the announcement on Jan. 7 of Eli Lilly’s (NYSE: LLY) intended $8 billion acquisition of Loxo Oncology (Nasdaq: LOXO). —Recommended Link— Market Rally Forecast For The Next 3 Days Did you know the stock market rallied during every government shutdown over the past 25 years? In fact, this time, it’s already up 10%… and still going. There’s a trade that exploits this situation exceptionally well, and you can take advantage of it over the next 3 days. You can find the full details here. I think we can expect even more deals as the year progresses. And that, of course, is potentially great news for investors… There are several industry-specific factors making it imperative that the flow of deals continues. For several years now, large pharma has been facing a crisis of sorts. The business model of drug companies has long been based on having… Read More
Since 1951, the American Cancer Society has been releasing a detailed report on the status of this dreaded disease, and our progress in fighting it. A valuable feature of these publications is their projections of the number of cancer cases and… Read More
Danger: Avoid These 5 Stocks At All Cost
With the recent market weakness, I think it prudent to follow up on what’s become a regular (and popular) feature. You see, while I mostly focus my attention on finding little-known, innovative companies that have the potential to deliver mega-returns to investors, I’ve consistently made the case that a big part of successful investing is often about what not to buy as well as what to buy. —Recommended Link— Legal? Completely. Simple? Definitely. Profitable? Hugely. You NEED to hear about this. If you’re looking for an innovative way to earn double and triple-digit gains then you don’t want to… Read More
With the recent market weakness, I think it prudent to follow up on what’s become a regular (and popular) feature. You see, while I mostly focus my attention on finding little-known, innovative companies that have the potential to deliver mega-returns to investors, I’ve consistently made the case that a big part of successful investing is often about what not to buy as well as what to buy. —Recommended Link— Legal? Completely. Simple? Definitely. Profitable? Hugely. You NEED to hear about this. If you’re looking for an innovative way to earn double and triple-digit gains then you don’t want to miss this. It’s completely legal and it doesn’t use options or leverage strategies. This is your opportunity to change the way you invest forever. The selloff in the stocks I spurned in this piece turned out to be much more devastating than in the market itself (which was horrific on its own). In the weeks between November 26 and December 26, the S&P 500 index declined 8%. During the same period, Diamond Offshore (NYSE: DO) lost 21.9%, Anheuser-Busch InBev (NYSE: BUD) lost 13.2%, Avon Products (NYSE: AVP) dropped 23.5% and Frontier Communications (NYSE: FTR) lost a whopping 35.4%. #-ad_banner-#I would… Read More
12 Stocks That Pass The ‘Bollinger’ Test
Almost anybody with interest in investing was glad to see 2018 come to an end. Of course, even as stocks continue to sell off, a selected few manage to buck the trend. —Recommended Link— Ex-Military Intelligence Officer Finally Reveals The Secret To Her 90.9% Success Rate Today only, get the system that is helping smart investors like you make massive gains for more than HALF OFF. Hurry, wall street insiders hope to shut this down soon… Click here before it’s too late. Such is the nature of the markets — some… Read More
Almost anybody with interest in investing was glad to see 2018 come to an end. Of course, even as stocks continue to sell off, a selected few manage to buck the trend. —Recommended Link— Ex-Military Intelligence Officer Finally Reveals The Secret To Her 90.9% Success Rate Today only, get the system that is helping smart investors like you make massive gains for more than HALF OFF. Hurry, wall street insiders hope to shut this down soon… Click here before it’s too late. Such is the nature of the markets — some stocks are attractive because of their perceived safety, some have such good news that even pessimists get convinced, a company or two might have been acquired during the period in question, and a few will attract buyers simply because of dirt-cheap valuation. #-ad_banner-#In today’s Fast-Track Millionaire stock screen, I’m going to show you those exceptional stocks that have bucked the S&P 500 trend — stocks that are on the move up, not down. Better yet, this screen aims to find stocks with positive trading signals, as defined by one of the most well-known technical indicators: Bollinger Bands. The theory behind… Read More
A New Solution To An Old Problem
The year has just begun, but the market has already experienced a jump in volatility, sending the S&P 500 up down 2.5% on a day only to bid it up more than 3% the very next trading day. Investors are searching for a direction… Read More
Even In This Market, Diversity Is Key
Needless to say, many investors are unnerved by the market action of late. This includes mighty Apple’s (Nasdaq: AAPL) shocking revenue warning and news this morning of a two-year low reading on an important factory activity gauge from the Institute for Supply Management. After the… Read More
Here’s How We’re Defying Gravity In This Market
We are only two trading days into the new year, but investors are already unnerved by the market action. This includes the mighty Apple’s (Nasdaq: AAPL) shocking revenue warning and news this morning of a two-year low reading on an important factory activity gauge… Read More
This ‘Opportunity Trade’ Has Earned Portfolio Status
—Recommended Link— Make a Small One-Time Payment… Get All Our Research for Life For a limited time only, we’re offering Lifetime VIP Membership at a huge discount. After a small one-time fee… you’ll never pay another penny again. Go here to try it out… Read More
5 Quality Tech Stocks At Bargain Prices
Over at my premium newsletter, Game-Changing Stocks, we often concentrate mostly on younger companies — those whose profit-making days are just beginning. But as investors, we cannot ignore inexpensive stocks. —Recommended Link— Christmas Savings Event — 85% Savings On Fast-Track Millionaire Until midnight tonight, we’re offering a special savings event. Fast-Track Millionaire is opening up 50 seats at an incredible 85% discount. Join hundreds of other investors already using this simple yet powerful system to generate millions. This year give yourself the gift of financial peace of mind. Remember, only 50 readers will be able to claim this incredible… Read More
Over at my premium newsletter, Game-Changing Stocks, we often concentrate mostly on younger companies — those whose profit-making days are just beginning. But as investors, we cannot ignore inexpensive stocks. —Recommended Link— Christmas Savings Event — 85% Savings On Fast-Track Millionaire Until midnight tonight, we’re offering a special savings event. Fast-Track Millionaire is opening up 50 seats at an incredible 85% discount. Join hundreds of other investors already using this simple yet powerful system to generate millions. This year give yourself the gift of financial peace of mind. Remember, only 50 readers will be able to claim this incredible discount. Don’t miss out. Click here for the full details. This month, I’m on the hunt for attractively-valued companies. Some of these bargains might have become cheap because of the recent market volatility, and for some, the attractive valuation would only be an indicator of deteriorating business or other issues. But you won’t ever know which one it is unless you start looking. Because of the many possible ways of defining “attractive” valuation, and because of the wide stock universe, I first needed to set a few restrictions. #-ad_banner-#First: only technology companies. That’s because these are the companies whose missions… Read More